Clinical Trial Update: The Drug-drug Interaction of SHR3824 and SP2086 [Phase 1]

View source ↗

Summary

A Phase 1 trial update evaluating the drug-drug interaction between SHR3824 and SP2086. The study targets individuals with Type 2 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR3824
• SP2086

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: UNKNOWN